HK$2.70
2.00%
Hong Kong, Sep 18, 03:59 pm HKT. Closed.
ISIN
KYG8406X1034
Symbol
2005

Ssy Group Stock price

HK$2.76
+0.35 14.32% 1M
+0.24 9.33% 6M
-0.08 2.65% YTD
-0.32 10.26% 1Y
-1.63 37.10% 3Y
-1.63 37.10% 5Y
+0.26 10.20% 10Y
-0.65 18.97% 20Y
Hong Kong, Closing price Thu, Sep 17 2026
+0.03 1.10%
ISIN
KYG8406X1034
Symbol
2005
Industry

Is Ssy Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
HK$8.0b
Enterprise Value
HK$10.2b
Net debt
HK$2.2b
Cash
HK$1.9b
Shares outstanding
2.9b
Valuation (TTM | estimate)
P/E
16.2
P/S
1.8 | 1.7
EV/Sales
2.3 | 2.1
EV/FCF
-
P/B
1.0
Dividends
DPS
HK$0.09
Yield 1Y | 5Y
3.1% | 3.7%
Growth 1Y | 5Y
-41.4% | -3.2%
Payout 1Y | 3Y
90.6% | 49.5%
Increased
0 Years
Financials (TTM | estimate)
Revenue
HK$4.4b | HK$4.8b
EBITDA
-
EBIT
HK$703.4m
Net Income
HK$507.5m
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
-4.4% | 15.4%
EBITDA
-
EBIT
-18.7%
Net Income
-23.0%
Free Cash Flow
-
Margin
Gross
41.4%
EBITDA
-
EBIT
16.1%
Net
11.6%
Free Cash Flow
-
Financial Health
Equity Ratio
57.0%
Return on Equity
6.5%
ROCE
6.6%
ROIC
5.5%
Debt/Equity
0.5
More
EPS
HK$0.2
FCF per Share
-
Short interest
-
Employees
5k
Rev per Employee
HK$760.0k

Ssy Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Ssy Group forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Ssy Group forecast:

Buy
88%
Hold
13%

Financial data from Ssy Group

Jun '26
+/-
%
4,379 4,379
4% 4%
100%
- Direct Costs 2,566 2,566
2% 2%
59%
1,813 1,813
7% 7%
41%
- Selling and Administrative Expenses 1,034 1,034
5% 5%
24%
- Research and Development Expense 197 197
12% 12%
4%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 703 703
19% 19%
16%
Net Profit 507 507
23% 23%
12%

In millions HKD.

Don't miss a Thing! We will send you all news about Ssy Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. The company employs 5,500 full-time employees The company went IPO on 2005-12-20. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.

Head office Cayman Islands
CEO Mr. Qu
Employees 5,472
Website www.ssygroup.com.hk

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today